The concept of ADCs was first proposed by Nobel Prize winner Paul Ehrlich in 1913. But it was not until 1975, when hybridoma technology began to be used to produce monoclonal antibodies, that the...
Using synthetic biology methods allows for the more efficient production of highly complex drug molecules compared to traditional chemical methods, with increased stability and controllability....
Antibody drug conjugates (ADCs)are a new class of biopharmaceuticals that use monoclonal antibodies to target tumor cells to deliver potent cytotoxic drugs. So far, a total of 15 ADC drugs have...
Introduction ofOligonucleotides
Oligonucleotide-based therapeutics represent a rapidly advancing field in current drug development. According to their therapeutic mechanisms, oligonucleotide...
BOC Sciences expressed its congratulations to Katalin Karikó and Drew Weissmanfor being recipients of the 2023 Nobel Prize in Physiology or Medicine.
The Royal Swedish Academy of...
Background
The use of small molecules to selectively regulate the function of proteins is the cornerstone of the development of medicine. However, only about 20% of proteins in human proteomes...
What are Biotinylation and Biotinylated PEG?
Biotinylation is the process of covalently attaching biotin to molecules (such as amino acids, peptides, antibodies, or proteins). Due to the small...
During the COVID-19pandemic, the success of mRNA vaccineshas greatly propelled the development of mRNA therapeutics. mRNA is a negatively charged nucleic acid that serves as a template for...
With the rapid development of antibody-drug conjugate(ADC), more and more companies have entered the field of ADC research and development, and various types of ADC technologies and branches...
siRNA, with a molecular weight of about 13 kDa, recruits the RNA-induced silencing complex (RISC) to mRNA through base pairing, thereby inhibiting protein translation. The mRNA is targeted for...
Cancer immunotherapy holds enormous potential in combating malignant tumors. Messenger ribonucleic acid (mRNA) has emerged as a widely studied tool in recent years, functioning within the...
Compared with viral vectors, non-viral delivery vectors are easier to scale up and have the ability to solve the most critical safety issues. Thanks to the LNP-mRNA vaccine that came to the fore...